Stay updated on Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial

Sign up to get notified when there's something new on the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Updates the ClinicalTrials.gov page revision identifier from v3.5.2 to v3.5.3, reflecting a site/version change rather than a modification to the underlying trial record.
    Difference
    0.1%
    Check dated 2026-04-24T06:20:17.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-17T02:39:56.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision history shows a new revision v3.5.0 added and an older revision v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-19T06:12:56.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The revision history shows a new entry for v3.4.3 added and the previous v3.4.2 entry removed.
    Difference
    0.1%
    Check dated 2026-03-12T02:37:33.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history; removed the funding notice and the earlier Revision: v3.4.1.
    Difference
    1.0%
    Check dated 2026-02-11T12:34:22.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added a Notice about a lapse in government funding stating that information may not be up to date and directing users to status sources. Updated the page revision to v3.4.1 and removed the previous v3.4.0 entry.
    Difference
    1.0%
    Check dated 2026-02-04T06:52:55.000Z thumbnail image

Stay in the know with updates to Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page.